This system recognized that sleep was not a steady state but consisted of cyclic patterns that varied in depth. In addition, Loomis et al 1 described the presence of brief alpha arousals that were associated with increased efforts to breathe and body movements, but these events were not included with the state scoring. The discovery of REM sleep and the development of the DementKleitman criteria, which incorporated REM sleep scoring rules, led to the formalized Rechtschaffen and Kales (R&K) manual for scoring human sleep.
were categorized by sleep stage and time of night by Halasz et al in 1979, 3 and empirical work linking brief arousals, sleepiness and sleep apnea in dogs was published in 1980. 4, 5 In the next 5 years, research showed significant correlations between brief arousals during sleep and daytime sleepiness, 6 began to examine different arousal definitions and their relationship to level of daytime sleepiness in different sleep disorder groups, 7 and empirically confirmed that the production of brief arousals during sleep produced increased sleepiness in humans. 8 
METHODS
The activities of the Arousal Task Force (see page 144) included development of this evidence review paper and participation in a RAND/UCLA Appropriateness Method consensus process for the development of scoring rules as part of the AASM scoring manual development project. 9, 10 The AASM scoring rules derived from this review paper and consensus will be published as a separate volume. 
Search terms and articles
The following string of search terms was used: Sleep and Arousals and EEG or "sleep fragmentation" or "sleep disruption." This generated 2415 references. The committee reviewed the abstracts of these papers for relevance to EEG arousal scoring, reliability, or validity. As a result, a total of 122 papers were selected, obtained, and made available to all committee members. Fourteen additional references were identified by pearling (identification of new references from the reference lists of already selected papers).
Evidence selection and grading
Task force members were assigned review topics (i.e., scoring reliability, arousal definition validity, clinical studies of arousal, and new measures of arousal), and committee members were free to review any of the papers included in their area of review. Papers reviewed for inclusion were required to present empirical data relevant to the section. Exclusion criteria included abstracts, reviews, theoretical papers, editorials, and case studies; these sources, however, were considered for the general introductory and discussion sections of the paper.
A data extraction sheet was developed prior to review of the articles. Each arousal paper was reviewed and summarized on the extraction sheet for the following information: study design, number and sex of subjects, types of arousal measures, study outcomes and outcome measures, significant results, evidence grade, and miscellaneous notes. Evidence grading was modified from Sackett 10 and is presented in Table 1 . An evidence table which summarizes all the extraction sheets has been provided at the end of each section of the paper.
BACKGROUND
As the role of arousals in sleep disorders and sleep restoration became more apparent, numerous studies were published. To encourage further research and allow consistency of definitions for arousals, in 1992 the American Sleep Disorders Association (ASDA, since named the American Academy of Sleep Medicine) published an arousal scoring manual for EEG arousals. 11 At that time, various methods of scoring arousals were discussed, and the 6 definitions of arousal that included both EEG and EMG changes and various duration criteria that had been published by Stepanski et al 7 were reviewed. It was concluded that a 3-second increase in EEG frequency, coupled with an amplitude increase in EMG, was the best predictor of level of daytime sleepiness. In the ASDA manual that followed, an EEG arousal was defined as "an abrupt shift in EEG frequency, which may include theta, alpha and /or frequencies greater than 16 Hz, but not spindles," which is at least 3 seconds in duration. The scoring rules required a concurrent increase in EMG to score arousals in REM sleep. These rules were consistent with scoring conventions in use by most labs prior to development of the manual, with the possible exception of the required EMG increase to score arousals in REM. As such, the use of the phrase "EEG arousal" in this paper should be considered similar to the ASDA definition unless otherwise specified.
Additional research has addressed the basic and clinical significance of EEG arousals. It is clear that EEG arousals occur as a typical feature of normal sleep. However, a good deal still needs to be known about arousals that may be pathological either by virtue of sheer number or by being markers for specific events. In addition, a number of definitional questions have arisen: It is known that EEG arousals are accompanied by a number of physiological changes. Some studies have found autonomic nervous system (ANS) signs of arousal (i.e., blood pressure changes, heart rate changes) in the absence of prominent EEG changes. 12 Do these ANS changes have functional significance by themselves? And if so, does that significance differ when an EEG arousal is present? Based upon scoring reliability issues, the ASDA arousal scoring criteria required that the EEG acceleration last for at least 3 seconds. It has been suggested that arousals of shorter duration may also be significant. In addition, computer scoring methods allow identification of arousals that are not visually scorable, and it is possible that these events may also have significance. 13 Finally, some have suggested that other events such as K-complexes or bursts of delta waves may also be forms of arousal that need to be considered, and there is continuing controversy concerning whether K-complexes and delta-bursts could reflect a "disruption" or a "protection" of sleep.
14, 15 If one considers that the R&K scoring system reflects the macrostructure of sleep, then the brief EEG/EMG/ANS arousals, however defined and interpreted, reflect the microstructure of sleep. It is the microstructure of sleep that is the focus of this review. The review is divided into an initial section that considers reliability and validity data to support arousals as described by the ASDA in 1992. 11 The second section reviews other types of arousal scoring that have been suggested, along with reliability and validity data when available.
RELIABILITY

ASDA arousal reliability
Several studies have addressed the reliability of scoring arousals with fewer papers reporting arousal scoring reliability values. An important determinant of ASDA arousal scoring reliability was the event duration. The ASDA manual specified a 3-second duration, but this decision was made on the basis of personal experience of several of the task members and not on systematic data. Several more recent studies have verified that decision. As presented in Table 2 (which can be accessed on the web at www. aasmnet.org), six level III studies demonstrated reliability using the standardized ASDA definition. [16] [17] [18] [19] [20] [21] and one study demonstrated reliability using the ASDA definition slightly modified for use with infants. 22 One additional level IV study performed prior to standardization of scoring rules but using similar rules was also included in the table. 7 Interscorer reliability for different definitions of arousals was assessed by Loredo et al in 20 subjects with and without obstructive sleep apnea. 17 Arousal scoring that used the ASDA definition had a 0.84 intraclass correlation coefficient (ICC) value, but the value dropped to 0.19 to 0.37 when shorter arousals were also scored. In another study of 20 children with obstructive sleep apnea syndrome and 16 healthy normals, 21 the ICC was 0.90 when arousals were scored based upon ASDA definitions and decreased to 0.42 when events of 2 seconds or longer were included. The ICC decreased further to 0.35 when one-second duration arousal events were also included.
Another factor evaluated was the addition of an EMG increase criterion during all sleep stages to the ASDA criteria. In the previously cited study by Loredo et al, the addition of the EMG criteria improved the ICC from 0.84 to 0.92. 17 Smurra et al assessed the addition of an EMG increase to ASDA scoring criteria in 20 patients with obstructive sleep apnea of varying severity. 18 They found the EMG criteria provided no further improvement. However, their reported ICC was already at 0.98 for the ASDA criteria. In a study that compared scoring between 14 different sleep centers on 90 events based upon sleep stage from which the arousal occurred, a kappa of 0.47 was reported. 16 On an event-by-event basis, this means agreement on 74 of 100 events. Comparing the REM kappa, which was higher, to the light sleep kappa led to the conclusion that EMG criteria could possibly provide better scoring reliability. Therefore, these studies generally support the use of an EMG criterion for a small increment in reliability.
The study by Drinnan et al 16 is the only study to have assessed the impact of sleep stage on arousal scoring; sleep stage might be expected to play a prominent role in reliability. Drinnan et al found that the highest kappa for arousal scoring was for arousals that occurred out of slow wave sleep. 16 In terms of signal-tonoise, the background EEG of slow wave sleep is much different from that of the low amplitude fast frequency of the arousal. In contrast, the background EEG in light sleep and REM sleep is of low amplitude with higher frequencies; these are more difficult to distinguish from lower amplitude and fast frequency shifts associated with arousals.
Another important factor, addressed by only one study, is the presence of additional cues on the polysomnogram (PSG) being scored. Many of the previously cited studies included respiratory tracings and, while not explicitly mentioned, probably also included EKGs. Thomas assessed arousal scoring reliability using ASDA criteria in 17 patients with obstructive sleep apnea syndrome. 19 The event-by-event scoring agreement between scorers was 91%. However, when the respiratory tracings were removed from the recording, the agreement dropped to 59%.
A final and obvious factor shown to affect scoring reliability is the experience of the scorers. A multicenter study assessed sleep stage (R&K) and arousal scoring (ASDA criteria) reliability of 30 unattended home polysomnograms. 20 An ICC of 0.54 was found for scoring arousals, and this figure improved to 0.76 when an inexperienced scorer was not included in the data set. In an infant study using slightly modified arousal scoring rules, 22 reliability, as calculated by kappa, was increased from 0.71 to 0.83 after additional training and from 0.83 to 0.86 after a month of additional experience.
Type of reliability
The majority of the studies discussed above assessed inter-rater reliability. One would expect intra-rater reliability to be higher than that of inter-rater reliability. The one study that compared intra-to inter-rater reliability found the event-by-event scoring agreement was 94% for the intra-rater scoring and 90% for the inter-rater scoring. 19 Finally, inter-rater reliability between centers is much lower than inter-rater reliability within centers. One study that compared arousal scoring from a set of 40-second samples sent to 14 laboratories found a kappa of 0.47 across laboratories, while another study across scorers in the same center found kappa in the range of 0.81 to 0.83. 16, 20 
Summary
These studies indicate that EEG arousals can be scored with relatively high reliability. For ASDA arousals, a 3-second duration criterion is necessary because reliability drops greatly when trying to score shorter events. There is no clear evidence to suggest that adopting EMG criteria for NREM sleep would greatly improve scoring reliability. However, extensive training and experience is necessary to develop highly reliable arousal scoring. Further, evidence that scoring reliability was reduced when assessed between centers indicates that additional training experience (such as provision of a set of "gold standard" scored polysomnograms) might provide benefit. Finally, cues from available tracings, beyond those specified for arousal scoring, could be used to improve arousal scoring reliability.
VALIDITY
Although brief arousals had been noted as normal occurrences during sleep for some time, it is the potential relationship between increased number of nocturnal arousals and increased sleepiness that has justified the time-consuming scoring process. Empirical evidence that supports the relationship between sleep continuity and sleep restoration will be reviewed in this section as a means of addressing the validity of arousal scoring. The major means of providing evidence for validity has been to vary arousals during sleep either empirically or through natural observation and to measure residual sleepiness. Change in function after sleep fragmentation can be compared with function after total sleep deprivation to determine the similarity between disturbance of sleep and complete loss of sleep. To the extent that these conditions are similar, i.e., to the extent that sleep fragmentation produces effects similar to that of sleep deprivation, measurement of sleep fragmentation parameters can provide an estimate of the means by which sleep restores normal alertness. The sections that follow will review evidence that arousals during sleep do reduce sleep restoration, the extent to which the reduction in function is similar to that seen after total sleep deprivation, and the extent to which similar arousal effects are seen in patients with sleep disorders such as sleep apnea syndrome. The extent to which clinical sleepiness resolves in patients when arousals are reduced will also be considered as evidence for validity.
The initial sections address validity as assessed from empirical animal and human studies. Twenty-one studies (8 level II [23] [24] [25] [26] [27] [28] [29] [30] and 13 level III, 8, 31, 32, 4, [33] [34] [35] [36] [37] 5, [38] [39] [40] ) provide evidence for the validity of arousals and are summarized in Table 3 (which can be accessed on the web at www.aasmnet.org).
Animal model
In dog studies published in 1980, 4, 5 novel auditory stimulation produced for 30-sec periods every 2.5 minutes for 2-3 nights resulted in dogs that appeared behaviorally sleepy and fell asleep significantly faster after being aroused. The dogs also had decreased O 2 and CO 2 sensitivity during sleep, along with decreased arousal responses to laryngeal stimulation.
Human model
The animal observations corresponded with sleepiness found in patients with fragmented sleep associated with sleep apnea and led to a number of studies in humans with the specific hypothesis that fragmentation of sleep by the production of brief, periodic EEG arousals at a sufficient rate would impair the process of sleep restoration and produce increasing sleepiness. The empirical studies performed in this area will be reviewed in the context of validity; that is, to what extent do graded changes in brief arousals produce predictable changes in selected outcome variables? Selected outcome variables have typically been chosen based upon their previously demonstrated sensitivity to sleep deprivation. Therefore, it is possible to compare the effects of various types of sleep fragmentation to periods of total sleep deprivation using the same measures and to determine the extent to which outcomes are similar or different.
It is known that the effects of total sleep deprivation are cumulative -that deficits become more extreme as sleep loss continues. It could therefore be hypothesized that deficits should also become more extreme as sleep fragmentation continues. Sleep deprivation is typically an all or none event (one is being sleep deprived or one is not). Sleep fragmentation differs in that it is a graded event. Arousals occur as a normal part of the sleep process. One can imagine arousals increasing in frequency to the point that they occur immediately after each sleep onset, resulting in total sleep deprivation and producing the same effects as total sleep deprivation. Such reasoning would imply that arousals produced at frequencies between these extremes might produce a wide variety of outcomes ranging from no effect to those consistent with no sleep. As such, it is possible to hypothesize that increases in the frequency of arousals should make effects more profound. The empirical literature was examined to determine the extent to which 1) deficits found after total sleep deprivation are also found in the same outcome measure or physiologic system after sleep fragmentation; 2) deficits found after sleep fragmentation accumulate with additional nights of fragmentation in the same way as they accumulate with additional nights of sleep deprivation; 3) deficits increase to approximate total sleep deprivation as the frequency of arousals within a night increase. To the extent that empirical studies support these contentions, arousals can be seen as meaningfully related to sleep restoration.
A number of outcome measures have been examined following both sleep fragmentation and sleep deprivation. Types of measures examined include psychomotor performance, sleepiness, hormones, respiratory function, metabolic rate, arousal threshold, EEG measures, and mood/subjective report. Sleep fragmentation studies examining these variables will be reviewed first, and 4 studies that directly compared sleep fragmentation schedules with sleep deprivation conditions within the same experiment will be reviewed second.
Psychomotor performance
Many empirical studies of sleep fragmentation have used psychomotor performance measures, often transferred directly from sleep deprivation studies, to document functional change after various schedules of fragmentation. Psychomotor performance changes following sleep fragmentation compared to baseline have consistently been in the same direction as seen after sleep deprivation, and significant impairment has been documented on a number of tasks including vigilance, 19 27 and trail making. 
Sleepiness
Objective sleepiness following sleep fragmentation has been measured with various sleep latency tests including both the multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT). One sleep fragmentation review paper summarized changes in sleep latency as a function of different schedules of sleep fragmentation using data from 8 studies. 41, 23, 26, 32, 28, 35, 37, 38, 30 Four level II 23, 24, 28, 30 and 4 level III studies 35, 37, 38, 42 assessed the validity of EEG arousal in relation to objective sleepiness, though methods in all of these studies preceded the standardized ASDA arousal definition. Daytime sleepiness increased as the rate of sleep fragmentation increased, with a significant correlation of r = 0.775 across studies between the interval of undisturbed sleep at night and sleep latency the next day. In other words, as the period of sleep allowed between empirically-produced disturbances decreased, latencies on nap tests on the following day became shorter.
Hormones
Spath-Schwalbe 39 studied cortisol and ACTH throughout baseline and sleep fragmentation nights (fragmentation after each minute of sleep). Plasma cortisol increased significantly when the experimental sleep fragmentation began. However, this burst of secretion was inhibited after about 80 minutes, and cortisol secre-tion dropped below baseline sleep levels before returning to normal. A similar but less pronounced effect was found for ACTH. Following total sleep deprivation, patterns of cortisol and ACTH resembled the pattern seen during sleep fragmentation. 39 Other hormones have not been studied in the empirical sleep fragmentation design. However, one study has shown delay of the testosterone rhythm in a design that allowed 7-minute sleep periods followed by 13-minute wake periods around the clock. 43 Patients with sleep apnea show decreased growth hormone and prolactin secretion at night. 44, 45 Although this decrease is probably secondary to sleep fragmentation and reverses after sleep is normalized, changes in these hormones have not been studied after simple sleep fragmentation.
Pulmonary Measures
Changes in pulmonary function related to sleep fragmentation were first directly studied in dogs. 4, 5 The initial studies documented decreased O 2 and CO 2 sensitivity and decreased arousal responses to laryngeal stimulation. In a later study designed to study either sleep fragmentation or sleep apnea in dogs for months, 40 it was shown that both the sleep apnea condition and the simple sleep fragmentation condition produced similar increases in the length of the time to arousal in response to airway occlusion. 40, 46 The study also reported greater tolerated oxygen desaturation, greater peak inspiratory pressure, and greater tolerated surges in blood pressure during airway occlusion following both sleep apnea and simple sleep fragmentation. Based upon these results, the authors concluded that "the changes in the acute responses to airway occlusion resulting from obstructive sleep apnea (OSA) are primarily the result of the associated sleep fragmentation." 40 An increase in the number of apnea/hypopnea events has also been shown after sleep fragmentation 46 in humans. Another study reported an increase in upper airway collapsibility and apnea/hypopnea index in normal subjects after sleep fragmentation. 29 Studies have not found changes in hypercapnic ventilatory responsiveness or in arousal responses to external inspiratory resistive loading after sleep fragmentation. 46, 47 In comparison to sleep fragmentation, total sleep deprivation has also been shown to produce longer apnea events in both infants 48 and adults. 49 Series et al 29 showed that the increase in apnea/hypopnea index after sleep fragmentation was actually greater than the increase after a similar amount of total sleep loss.
Metabolic measures
One study recorded whole body metabolic rate (VO 2 and VCO 2 ) during baseline, sleep fragmentation, and recovery nights. 32 Significant elevation of VO 2 was found during the fragmentation night as compared to baseline. Significant decreases in VO 2 were found during the recovery night compared to baseline. Metabolic rate increases during wake compared to sleep and decreases as subjects move from stage 1 to stage 4, 50 but changes in metabolic rate have not not been reported during recovery from total sleep deprivation.
Arousal threshold
Many sleep fragmentation experiments have used auditory stimuli to produce fragmentation, and when graded stimuli have been used, auditory threshold to the production of an arousal response has been reported. Studies have shown significant increases in auditory arousal threshold during 2 nights with EEG arousals placed after each 1 minute or 2 minutes, but not after 60 minutes of sleep. 8, 25, 26 One study 8 used occasional novel tones to measure the extent to which the increase in auditory threshold was secondary to sleep fragmentation as compared to habituation and concluded that about 67% of the increase in arousal threshold was related to the fragmentation procedure. Increased arousal threshold of a similar magnitude was found during recovery sleep following total sleep deprivation 51 compared with baseline sleep.
EEG measures
Two studies reported that visual evoked responses had decreased amplitude at several sites (frontal, central, and temporal) after sleep fragmentation, but significant increases in latency were not found 34, 33 In comparison, significantly decreased amplitude and increased latencies for visual evoked responses have been reported from a central site after one night of total sleep loss. 
Mood/subjective measures
A number of measures, including visual activation scales, the Stanford Sleepiness Scale, and several mood scales such as the Clyde Mood Scale and the Profile of Mood States (POMS), have been used to assess sleepiness and mood in both sleep fragmentation and sleep deprivation studies. Significant increases in subjective sleepiness have been reported in several studies after sleep fragmentation. 8, 24, 25, 31, 26, 34 Following sleep fragmentation, mood measures become more negative, 33, 35 including increased irritability, 33 increased tension, 33 increased anger, 25 decreased clear thinking, 8, 25, 24 and decreased friendliness. 25 Increased subjective sleepiness is a universal finding in total sleep deprivation studies. 54, 55 Other mood changes have been typically linked to the sleepiness dimension and include increased fatigue and decreased vigor. 55 
Accumulating deficits
One early study of sleep fragmentation showed that auditory thresholds and ratings of depth of sleep increased significantly both across nights of sleep fragmentation and overall from the first to second night of disturbance. 8 Several other studies have shown greater impairment following a second night of sleep fragmentation as compared to the first night on a number of measures including arousal threshold, 31, 25 psychomotor performance, 24 spectral EEG parameters, 33 and mood. 8 Other studies that have not shown significant differences from the first to second disturbance night still typically have shown trend increases in sleepiness following the second night as compared to the first night. 30, 38 Such findings confirm that sleep fragmentation produces cumulative effects across time in a manner that is similar to that seen after total sleep deprivation.
Sleep fragmentation versus sleep deprivation deficits
Four empirical studies directly compared total sleep deprivation and sleep fragmentation within the same experiment. 27, 23, 39, 29 The studies compared total sleep loss for one or two 23 nights with similar periods of sleep fragmentation. Sleep fragmentation was produced following each minute of sleep in 3 studies and at each onset of stage 2 in the fourth. Levine et al 27 reported that MSLT was reduced after both total sleep deprivation and 1-min sleep fragmentation, and these conditions did not differ statistically (the actual latencies were respectively 2.2 and 4.1min). Bonnet 23 reported that performance deficits were significantly greater following total sleep deprivation than following 1-min sleep fragmentation on number of addition problems completed and simple reaction time. However, deficits were similar, i.e., significantly different from baseline but not different from each other, on vigilance hit rate (25% vs. 25%) and on nap latency (2.2 vs. 3.7 min.) after total sleep deprivation as compared to sleep fragmentation. Spath-Schwalbe 39 showed that cortisol and ACTH peaked shortly after the initiation of sleep deprivation or sleep fragmentation and then showed a similar pattern of inhibition followed by a later peak in both sleep deprivation and sleep fragmentation conditions. This pattern was different from the normal sleep condition. Series et al 29 found a significant increase in apnea/hypopnea index after sleep fragmentation, and this increase was actually greater than that found after a similar period of total sleep deprivation. This finding is the single instance in which the effects of sleep fragmentation have been reported to be more extreme than a comparable period of total sleep loss.
Recovery
In early sleep fragmentation studies, the fragmentation procedure typically produced large decreases in SWS and REM. 8 Recovery sleep was also noted to have predominant SWS rebound that was similar in magnitude to that seen after total sleep deprivation. 8 Three more recent studies have sought to produce less change in sleep stages by more careful arousal technique. 33, 36, 30 Unfortunately, only one of these studies also recorded a recovery night following the fragmentation procedure. Cote et al 33 showed significant decreases in mood and in spectral EEG parameters after sleep fragmentation with no significant changes in TST, SWS, or REM from baseline to fragmentation nights. However, REM percent was decreased on the first fragmentation night as compared to the second fragmentation night, and this change was supported by a significant decrease in REM latency on the second fragmentation night as compared to baseline. The latency to stage 3 was also significantly decreased on the second fragmentation night and recovery night as compared to the first fragmentation night. Such changes indicate that the magnitude of sleep stage recovery values may be dependent upon the disturbance paradigm. However, as all 3 studies that have minimized sleep stage disturbance have nonetheless reported significant changes in sleepiness or mood after the disturbance nights, it is apparent that the sleep fragmentation continued to produce deficits despite lack of impact on traditionally scored EEG sleep stages. Unfortunately, such studies have not been done with control groups experiencing total sleep deprivation or more invasive fragmentation to be able to determine which part, if any, of the large deficits reported in earlier sleep fragmentation studies were related to decreases in sleep stage amounts and which were related to fragmentation itself. This issue of specific sleep stage effects, however, has also been examined in a design which sought to control the amount of sleep fragmentation, while at the same time maximizing or minimizing SWS. In that study, similar decrements were found after both (equivalent) fragmentation conditions even though the amount of SWS was experimentally varied to be significantly greater in one of the conditions, again supporting the contention that the fragmentation rather than sleep stage amounts was determining the deficits. 24 
Summary
Both animal and human studies have shown that empirically produced brief EEG arousals produce increased sleepiness and decreased responsiveness to respiratory stimuli. Studies in humans have reported increased objective and subjective sleepiness, decreased psychomotor performance on a number of tasks, changes in hormone secretion pattern, decreased upper airway function, increased whole body metabolic rate, increased sensory arousal thresholds, and decreased amplitude in evoked responses following various schedules of sleep fragmentation as compared to baseline. In all cases, these changes were in the same direction as those seen after total sleep deprivation. Several studies have shown that changes in mood, arousal threshold, psychomotor performance, and spectral EEG parameters, as with sleep deprivation, become significantly more extreme as a function of increasing nights of disturbance. Studies directly reporting outcome measures after high frequency sleep fragmentation as compared to total sleep deprivation have shown that some psychomotor performance measures are not affected as strongly by sleep fragmentation as by total sleep deprivation but that other measures of psychomotor performance and objective sleepiness are equally affected by sleep fragmentation and sleep deprivation. One study 29 has actually shown a greater increase in apnea/hypopnea index after sleep fragmentation as compared to total sleep deprivation. Sleep stage rebounds commonly found after total sleep deprivation are also seen after empirical sleep fragmentation. The extent of sleep stage rebounds seems to be related to the specific decreases in those sleep stages based upon the sleep fragmentation design. However, at least 3 experiments have shown that empiric sleep fragmentation continues to produce next-day deficits, even when total sleep time and sleep stage amounts are preserved in a sleep fragmentation design.
Taken as a whole, these studies indicate that brief, frequent, periodic disturbance of the ongoing EEG during sleep as described by the ASDA 11 produces numerous physiological and behavioral changes similar to those produced by total sleep deprivation.
Predicted changes in arousals in sleep disorders
Arousals play a prominent role in sleep disorders. A number of clinical studies have examined the direct relationship between arousals in patients and functional outcome variables including changes in function with treatments that decrease arousals. The 16 studies (4 level II, 56, 57, 42, 58 3 level III, 59-61 and 9 level IV, 7, [62] [63] [64] [65] [66] [67] [68] [69] ) that provide clinical evidence for the validity of arousals are summarized in Table 4 (which can be accessed on the web at www. aasmnet.org).
Arousals on baseline and recovery sleep nights
There are significant changes in sleep stages and arousal threshold during recovery sleep following sleep deprivation. If EEG arousals are related to the sleep restoration process, it could be hypothesized that the number of brief arousals should also be reduced in recovery sleep after sleep deprivation. Two studies have examined this hypothesis. In one, 70 arousal index was significantly decreased from 16.2 to 8.3 during recovery sleep following 64 hours of total sleep deprivation in normal adults. In a second study, 71 arousal index was significantly reduced from 12.3 during baseline sleep to approximately 11 after 2 nights of SWS deprivation and to approximately 8.5 after one night of total sleep deprivation.
Arousals in patients with sleep associated respiratory problems
The above sections examined evidence regarding the impact of arousals on human and animal functioning following experimentally induced sleep fragmentation. In this section, the evidence for a relationship between arousals and other measures of impairment will be examined. The primary questions being asked are: 1) to what extent do arousals predict daytime impairment, and 2) to what extent would the dissipation of arousals following treatment result in a diminution of this impairment?
Stepanski and colleagues 7 performed the first systematic examination of the relationship between sleep fragmentation and daytime sleepiness in various conditions. They utilized correlational techniques to evaluate this relationship in patients complaining of excessive daytime somnolence (EDS) associated with sleep apnea (n = 15), periodic leg movements in sleep (PLMS) (n = 15), patients complaining of insomnia (n = 15), and healthy volunteers with no sleep complaints (n = 10). One night of PSG followed by an MSLT was obtained for each subject. Across all subjects, the total number of arousals was related to the MSLT-based sleepiness index (MSLT sum of latencies to stage 1 sleep on 4 nap tests multiplied by 1.25 and subtracted from 100; r = 0.48, p < 0.001). ) and R&K awakenings. They found significant relationships between arousals scored by any definition and mean sleep latency on MSLT. However, no relationship existed between arousals or awakenings and ESS. Therefore, the connection between arousals and objective measures of daytime somnolence appears to be supported.
In sleep related breathing disorders, an important question is the relative contribution of EEG arousals, as opposed to the variety of other measures of illness severity such as hypoxemia, AHI, etc. to daytime impairment. In the study by Martin et al, 64 arousals did predict the degree of objective daytime somnolence, and there was no relationship between R&K awakenings and MSLT mean sleep latency. However, the best predictor of MSLT sleep latency was the AHI. Roehrs 61 compared 152 patients with OSA or primary snoring to 45 healthy controls by administering various measures of daytime sleepiness and psychomotor impairment including the Stanford Sleepiness Scale (SSS), Psychomotor Vigilance Task (PVT), MWT, and Epworth Sleepiness Scale (ESS). They noted that the number of arousals was lowest in snorers and increased with increasing AHI. There was no relationship between arousal frequency and reaction time (RT), yet there was a positive relationship between arousals and false responses, and arousals and lapses, on PVT. However, other measures of sleep related breathing disorder severity, such as AHI, SpO 2 , and sleep architectural impairment, such as total sleep time (TST) were also related to measures of daytime impairment. Pitson et al 66 also examined 40 OSAS patients and noted a good correlation between EEG arousals and various other measures of apnea severity such as SpO 2 dips (r=0.69) and AHI (r=0.68). However, the relationship between all types of arousals (in addition to EEG arousals, the authors examined pulse transit time and heart rate arousals) and ESS was poor, being significant only for SpO 2 dips. Non-EEG arousals, such as autonomic arousals, pulse transit time swings, and heart rate rises/hour have been less promising predictors of EDS. 68 Other investigators have extended these findings by examining the relationship between arousals and other disease-associated impairments. Lafoso et al, 63 for example, studied 105 subjects with the complaint of snoring but not meeting polysomnographic criteria for OSAS (AHI<10, AI<5, duration of episodes of SpO 2 <90% of less than 1 min). Nonapneic snorers were classified as sleep disrupted or not sleep disrupted based on arousal index threshold of 10. The group was assessed for the presence or absence of a history of hypertension (previous diagnosis of hypertension and treatment with antihypertensives, diastolic BP >95 and/or systolic BP >160 within 3 months of the onset of the study). They noted that hypertension was more prevalent in the group with sleep fragmentation and suggested that sleep fragmentation in snorers may play a role in genesis of systemic hypertension. In a separate investigation, Noda et al 65 examined 26 OSAS patients by separating them on the basis of presence or absence of hypertension (BP >140/90). They then assessed possible differences between the 2 groups on various polysomnographic variables such as AHI, total time with SpO 2 below 90%, SpO 2 nadir, EEG arousals, and movement arousals, as well as 24-hr systolic and diastolic BP measured at 30-min intervals. They noted that the frequency of movement arousals and decrements in SpO 2 , in that order, made the most significant contributions to increased 24-hr systolic and diastolic BP. The hypertensive group had a higher frequency of EEG and movement arousals.
Taken collectively, the data suggest that sleep fragmentation is an important predictor of daytime impairment in areas such as alertness/wakefulness and psychomotor functioning, and possibly even hypertension. The relationship is better noted in objective, rather than subjective, measures of EDS. However, other measures of apnea severity, such as the extent of hypoxemia and AHI, are also related to daytime function, and the studies cannot conclusively answer the fundamental question of how these pro-cesses are related to one another and to arousals. That is, they do not answer the question of whether these changes produce their effects on daytime function independently or through their effects on arousals. Also, although EEG arousals are important predictors of EDS in OSA and PLMS, their relative position in the hierarchy of all contributory variables is unclear.
If arousals cause daytime impairment, then their diminution should lead to an improvement in daytime function. Bennett et al 59 assessed daytime somnolence utilizing the ESS and OSLER test in 41 subjects who were comprised of nonsnorers, simple snorers, and OSA patients undergoing treatment with CPAP. In addition to ASDA arousals, they examined autonomic arousals and movement events. All markers of sleep fragmentation (arousals) had significant associations with baseline EDS and its improvement with nC-PAP at similar magnitudes. AHI was also correlated closely with sleepiness and its response to treatment. However, no significant relationships could be found between any of the sleep fragmentation indices and post-nCPAP objective sleepiness measures. Multiple regression analysis indicated that the best predictor of the pretreatment objective sleepiness was the movement event index. In a separate investigation, Bennett et al 60 also examined SF-36 health status and noted that it improved following CPAP treatment in 51 OSA patients, and noted a significant, yet weak, relationship between change in health status following CPAP treatment and sleep fragmentation indices. Colt and colleagues 72 examined the relative contribution of arousals and other measures of apnea severity such as hypoxemia and AHI, to EDS in 7 OSA patients undergoing treatment with nCPAP. In this crossover design, patients were exposed to either nCPAP, or nCPAP plus induced hypoxemia for 2 nights. Both conditions resulted in improved MSLT sleep latency to the same extent. Therefore, the induction of hypoxemia did not diminish the improvement in objective measures of daytime somnolence, and this gavefurther support to the relationship between sleep fragmentation and EDS.
The presence of EEG arousals helps to identify upper airway resistance (UARS). One study has specifically examined differences in arousal variables in patients with mild sleep apnea as compared to patients with UARS. 69 The notable finding was that, in terms of EEG arousals, there were almost no differences between the groups. Significant differences in the study were primarily based upon group selection; that is, apnea patients had significantly increased respiratory events associated with visually scored EEG arousals as would be expected by selection.
The only investigation of the relationship between sleep fragmentation and EDS in central sleep apnea (CSA) syndrome was performed by Bonnet et al, 57 who treated 5 male CSA patients with placebo and triazolam (0.125 and 0.25 mg) in a doubleblind crossover design. Daytime function was assessed by MSLT, POMS, short-term memory, Wilkinson Addition, Wilkinson Vigilance, and SSS. The triazolam condition was associated with a decrease in arousal and central apnea indices, as well as an improvement in next day psychomotor performance and a reduction in subjective sleepiness on SSS. MSLT sleep latency increased, but the change was not statistically significant. The medication was also associated with an increased total sleep time. The lack of improvement in objective EDS measures, despite improvement in subjective EDS measures and other performance measures in the face of diminished arousals may have been related to the small sample size.
Arousals in patients with periodic limb movements
A number of investigations have examined the relationship of arousals to EDS in patients suffering from periodic limb movement disorder (PLMD) prior to and following treatment. Doghramji et al, 58 in a placebo-controlled crossover design, assessed the effects of triazolam 0.25-0.5 mg in 15 PLMD patients with EDS. At end of the treatment period (4-7 days), triazolam was associated with a significant increase in MSLT mean sleep latency score, yet there was no change in SSS score. Treatment was associated with no change in the PLM index, despite a decrease in the PLM arousal index and total arousal index. Other measures of sleep architecture, such as TST, TWT, and percentage of stage 1 sleep, also revealed improvement. This study showed that improved sleep is associated with improved daytime function, yet it is unclear whether that benefit should be attributed to changes in the arousal frequency alone or to changes in other sleep architectural factors as well. The possibility that arousals are not important contributors to EDS was apparent in an investigation by Bonnet et al 56 in another placebocontrolled crossover investigation of the effects of triazolam 0.125 mg and 0.25 mg in 11 sleepy PLMD patients. They assessed daytime function via auditory vigilance tests, POMS, and short-term memory testing. They noted no change in total leg movements or arousals, yet there was an increase in TST and SE and a decrease in the number of stage changes. A parallel improvement in MSLT sleep latency and cognitive measures was also noted. Therefore, the improvement of daytime performance and alertness appeared to be independent of the medication's effects on arousals. In a similar investigation of 9 PLMD sufferers, which was followed by a 12-week open-label phase, Bonnet and Arand 42 noted that triazolam 0.25 mg did not decrease the arousal index; in fact, the medication was associated with an increase in EEG arousals in the late drug-treatment phase. Nevertheless, daytime function improved as assessed by vigilance performance, short-term memory, and some MSLT results. Sleep continuity variables and TST improved. When EEG arousals were corrected for both the increase in total sleep time and the associated increase in limb movements, there was a significant decrease during early medication administration. However, the fact that EDS and sleep variables improved more than arousals improved suggests that EDS may be based on a variety of nocturnal factors in addition to arousals.
These treatment data yield mixed results. On the one hand, they suggest that arousals are linked, at least at baseline, to severity of EDS and other psychomotor function indicators. However, whether the changes noted in daytime measures during and after treatment are due to changes in arousals is not altogether clear, possibly owing to the complex effects that medications have on a variety of measures of sleep architecture.
ONTOGENY
EEG arousals are ubiquitous throughout the human life span during sleep. Because failure of arousal has been considered an important issue in sudden infant death, a number of studies have examined the process of arousal in infants. These studies generally do not apply to the current examination of reliability and validity of arousal scoring in adults with the exception that the ASDA scoring criteria have been used in several studies. One study 22 has shown high arousal scoring reliability in infants with only minor scoring modifications, specified word for word in the publica-tion. In a study of 5-year-old children, arousal reliability was also shown to be high using the standard ASDA criteria. 21 Specific studies of the reliability or validity of arousals are also uncommon in older adults. Three papers have examined EEG arousals across broad age bands. One study found no significant difference in arousal index when comparing groups of young (20-35 years) and older (50-65 years) normal sleepers. 73 However, 2 other studies have both reported significant positive correlations of EEG arousals with age. 74, 75 This correlation was associated with a significant increase in arousal index from 13.8 (SD 2.2) in teenage subjects to 27.1 (SD 3.3) in 60-to 80-year-old subjects in one study. 74 
OTHER MEASURES OF AROUSAL
It is recognized that visual scoring of EEG arousals according to ASDA criteria is just one approach to characterizing the degree of sleep fragmentation. Scoring EEG arousals is the best-validated approach and has replaced earlier measures used to quantify sleep fragmentation (e.g. amount of stage one sleep, number of awakenings). However, the number of EEG arousals does not always have a high correlation with subsequent daytime sleepiness. New measures may be developed that quantify sleep fragmentaion more precisely and provide more accurate prediction of subsequent daytime impairment. Attempts to improve this measure of sleep fragmentation have primarily involved other measures of EEG activity or measures of autonomic activity. Other approaches to quantifying sleep fragmentation are described below.
Cyclic alternating pattern
In 1985 the cyclic alternating pattern (CAP) was described as a physiological component of normal NREM sleep. 76 CAP also addressed periodic arousals occurring during sleep and described 3 different types of EEG arousal that occurred spontaneously in cycles as a normal characteristic of sleep. This system focused on NREM sleep alone, viewing these arousals as a characteristic of normal NREM sleep. The role of arousals, according to the theory underlying CAP, differs markedly from that underlying ASDA EEG arousals. CAP researchers believe that arousals occur either as increases or decreases in EEG frequency and that some of these events may protect sleep from disruption. Therefore, these arousals do not necessarily signal decreased sleep quality. As such, the use of the term "arousal" may be confusing.
A CAP scoring manual was published in 2002. 77 It defined 3 subtypes of arousal that constitute the A phase of the CAP pattern which is followed by the B phase of the pattern, a period without arousals. The EEG of the A1 subtype is characterized by a predominance of delta wave bursts, K-complex sequences, and vertex sharp transients. The A2 subtype is an admixture of slow and fast rhythms, while the A3 subtype is a predominance of fast rhythms.
Arousal-related phasic events occur in CAP, interrupting tonic NREM (or NCAP). It is hypothesized that understanding the interplay between CAP and NCAP states is important in appreciating the role of microarousals as normative phenomenon versus signs of pathology. However, the research in this area is at an early stage, and the significance of CAP is unclear. Investigations of CAP have primarily focused on viewing arousal as an oscillating phenomenon with an adaptive function, rather than a measure of the degree of sleep disturbance.
Three studies from those summarized in Table 5 (which can be accessed on the web at www.aasmnet.org), have measured both ASDA arousals and CAP. 78, 79, 70 One evidence level IV study showed a statistically significant relation between the occurrence of ASDA arousals and certain subtypes of CAP activity. 78 In particular, subtypes A2 and A3 of CAP had a significant correlation of 0.84 (p<.0001) with ASDA-scored arousals. Two evidence level III studies examined the effect of sleep deprivation on CAP activity. 79, 70 DeGennaro et al 79 found that CAP and ASDA arousals were both decreased during recovery sleep following a night of sleep deprivation. 79 Subtype A3 of CAP correlated 0.79 with ASDA arousals on the baseline night and 0.95 on the recovery night. Another study 70 reported a significant decrease in ASDA arousals during sleep following 64 hours of total sleep deprivation but did not find a significant change in either delta bursts or K-complexes (corresponding to the A1 phase of CAP) on the recovery night.
Evidence for validity/reliability of CAP arousals
One level III study has been done assessing CAP interrater reliability in a group of 11 normal adults, and it reported a Kendell W coefficient of concordance value of 0.90 for the various CAP parameters. 80 A standard approach to computing CAP with computer assistance has been recently published, 80 and this should lead to additional systematic studies.
Evidence for relation of CAP to sleep restoration independent of ASDA arousals
There are no data relating CAP measures to severity of daytime impairment. The studies comparing CAP to ASDA arousals have not included measures of daytime function. As a result, there are no validity data available.
Advantages/Disadvantages of CAP Compared with ASDA arousals
In summary, studies measuring CAP have not shown superiority of this approach in the measurement of sleep disruption or as a predictor of daytime impairment, compared with the ASDA arousal measure. Measurement of CAP is more time consuming than scoring of ASDA arousals. It can be argued that the high correlation between the A2 and A3 subtypes of CAP with ASDA arousals makes those measures similar (differing perhaps only in that ASDA arousals are scored during REM while CAP is not). The major theoretical question is whether the CAP A1 subtype, correlated with delta and K-complex activity, is actually an arousal event that might increase the predictive ability of ASDA arousals to identify nonrestorative sleep or a sleep protective event that does not inhibit sleep restoration. Direct tests of the role of Kcomplexes or evoked delta in limiting sleep restoration have not been published, but one study that actually produced consistent K-complex type responses during sleep at a periodicity of 22 sec for 30 consecutive nights did not report any signs of decreased function or increased sleepiness. 81 This finding, in conjunction with the finding of Sforza et al of no change in these delta events after sleep deprivation 70 supports the contention that these evoked delta and K-complex events are inherently different from ASDA arousals and should not be included with them in traditional arousal scoring. Overall, there is insufficient evidence at this time to use CAP in the routine assessment of arousals during sleep for the purpose of quantifying sleep fragmentation.
Measures of autonomic arousals
A number of studies have explored the utility of measuring autonomic events, usually blood pressure or heart rate changes, as a way to quantify arousals during sleep. This work is based on the observation that changes in measures of autonomic function, such as increases in arterial blood pressure, occur in response to acoustic stimuli 12 and at the conclusion of obstructive respiratory events. 82 Studies of autonomic arousals have generally addressed one of the following 3 areas: 1) the utility of using autonomic arousals as a screen for sleep disordered breathing, 2) use of autonomic arousals as a more easily scored proxy for EEG arousals, or 3) autonomic arousals as a predictor of daytime sleepiness as compared to EEG arousals. The first of these questions is beyond the scope of this paper and will not be addressed. The other 2 questions are related to the goals of this paper, and relevant studies are reviewed below. Twelve studies, including 6 level III studies, 32, 83, 12, 36, 82, 81 5 level IV studies, 84, 85, 66, 69, 68 and 1 level V 86 study are summarized in Table 6 (which can be accessed on the web at www.aasmnet.org).
Autonomic arousals and daytime sleepiness
Autonomic arousals occur with obstructive respiratory events and with snoring, even in the absence of EEG arousals. 82, 86 Autonomic arousals have also been detected in normal sleepers in response to experimental stimuli when EEG arousals did not occur. 85, 83 In contrast, EEG arousals were always accompanied by an autonomic arousal in those studies. These results suggest that autonomic arousals have a lower threshold and are more sensitive to perturbations in the CNS during sleep. Therefore, it is theoretically possible that these events may be a more accurate indicator than EEG arousals of CNS changes sufficient to cause daytime impairment. However, research investigating this topic has not shown a convincing relation between autonomic arousals and sleepiness that is independent of the co-occurrence of EEG arousals.
Pitson and Stradling 66 correlated standard EEG arousals with 2 measures of autonomic arousals (blood pressure arousals and heart rate arousals) in patients undergoing screening for OSA. They found significant correlations between all the arousal measures (0.51-0.67). All arousal measures were also significantly correlated with AHI and SpO 2 dips. No arousal measure was significantly correlated with the ESS, but there was a low significant correlation with SpO 2 dips (r=0.36). Another study investigated the importance of autonomic arousals associated with snoring or sleep-disordered breathing in causing sleepiness. 68 The investigators obtained a large sample (n=473) from the general community and found no relation between blood pressure changes using pulse transit time (PTT) and sleepiness measured by the ESS. One criticism of these studies is the use of a self-report measure of sleepiness that has a low correlation with objective measures of sleepiness.
Experimentally induced autonomic arousals administered to normal sleepers have been reported to increase daytime sleepiness. 36 In this study, tones were presented in a manner to produce increases in blood pressure or heart rate while attempting to avoid producing ASDA arousals; MSLT and MWT were used as outcome measures. It was concluded that events associated with the autonomic arousals, but not EEG arousals, were sufficient to decrease the restorative value of sleep (i.e., a significant decrease was found for MSLT and MWT). However, about 20% of the tones administered in this study caused EEG arousals, and these arousals may have played a role in the increased sleepiness observed in these subjects. The authors argue that because the overall number of EEG arousals did not differ between baseline and disrupted nights, the change in MSLT is solely attributable to the autonomic arousals. This rationale assumes that induced arousals and spontaneous arousals are equal in their distribution and likelihood of contributing to daytime sleepiness. It is commonly observed in studies utilizing experimental sleep fragmentation procedures that spontaneous arousals are decreased on nights when sleep is experimentally fragmented. 81 It has also been shown that longer arousals have a greater physiological impact than shorter arousals. 32 Therefore, the effects of the induced autonomic arousals are confounded by an increase in the number of longer experimentally induced EEG arousals in this study.
Predicting EEG arousals from autonomic arousals
Another area of interest related to autonomic arousals is the possibility that these events can be used to estimate the number of EEG arousals. Scoring EEG arousals is time-consuming and requires a well-trained staff to achieve acceptable reliability. Since autonomic arousals can be computed by online analysis, this approach to quantification of sleep fragmentation is potentially much faster. Catcheside et al 83 found that PTT and skin blood flow (SBF) are superior to HR in predicting EEG arousals. In that study, auditory stimuli administered to normal sleepers produced 85% agreement (measured as ROC area) between EEG arousals and PTT, as well as between blood pressure changes and EEG arousals. However, PTT has not been shown to be a reliable predictor of EEG arousals in patients with sleep disordered breathing. 69 Poyares et al 69 found that PTT predicted EEG arousals with a sensitivity of 90.4% but a specificity of only 16.8%. Adachi et al 84 used various autonomic arousal indices in an attempt to identify patients with frequent EEG arousals (>30 arousals per hour of sleep). They found that autonomic arousal measures tended to overestimate the frequency of EEG arousals, and the greatest mismatch occurred in mild cases with a low number of EEG arousals.
Another aspect of this area of research that requires further assessment is the association between autonomic arousals and EEG changes that do not meet traditional criteria for EEG arousal. The term "subcortical arousal" has been used to describe autonomic measures and differentiate them from traditional EEG-based measures of arousals. However, it may not be accurate to characterize these events as purely "subcortical" since investigators have noted changes in the power density of the EEG in conjunction with autonomic arousals even in the absence of traditionally defined EEG arousals. 82, 36 Quantification of the changes in power density of the EEG may be useful in further understanding what types of events are predictive of sleepiness. 82, 36 
Summary
Studies comparing autonomic measures with standard EEG measures of arousal consistently show that EEG arousals are associated with reliable changes in autonomic measures. Further, it has been shown that autonomic arousals may be caused by external stimuli as well as obstructive breathing events in the absence of EEG arousals. However, the significance of autonomic arousals that are not associated with EEG arousals in contributing to daytime impairment is uncertain. Studies have not shown that autonomic arousals without EEG arousals are predictive of daytime sleepiness.
OVERALL SUMMARY
Utility of arousal scoring
Several studies have reported that arousals, as defined by the ASDA in 1992, can be scored reliably. A number of variables, such as training and additional recording channels, have been shown to increase scoring reliability. Other variables, such as decreasing the length of time required to score an arousal, have been shown to decrease measure reliability.
A number of empirical studies in animals, humans, and clinical populations have shown links between the frequency of EEG arousals and daytime sleepiness. Increasing the frequency of arousals and the number of nights during which arousals are induced increases residual sleepiness, and this effect is independent from reduction in EEG sleep stage amounts. In addition to sleepiness, sleep fragmentation produces numerous effects such as decreased psychomotor performance, degraded mood, altered hormone secretions, decreased pulmonary function, altered metabolic rate, increased arousal thresholds, and alteration in EEG evoked responses similar to that seen after total sleep deprivation. Sleep fragmentation may also result in sleep stage rebounds or decreased arousals during recovery sleep. Finally, patients with sleep fragmented by respiratory or movement disorders have been shown to have improved alertness and psychomotor function when arousals during sleep have been reduced.
These findings continue to support EEG arousals as an important component of the sleep process. As such, the scoring of EEG arousals is essential in clinical PSGs as a means of determining the extent to which daytime compromise is specifically related to sleep disturbance and to give treatment and treatment response guidelines to practitioners.
Potential for integration with new measures
Despite the empirical data that link arousals with daytime function, important questions remain. In clinical studies, the correlation between sleep fragmentation measures and daytime sleepiness frequently accounts for only a small part of the total variance. Reliable scoring of arousals is a difficult and time-consuming process. A number of new measures have been proposed to deal with these issues. Investigators have shown that several new measures are correlated at a relatively high level with ASDA arousals and with outcome variables such as sleepiness at a level similar to that seen with ASDA arousals. Unfortunately, because these are correlation studies, the independent effect of these new measures beyond the known effect of ASDA arousals on daytime outcome measures is unknown. For example, automated measures of heart rate or PTT are easy to make and are related to EEG arousals in patients. Unfortunately, no study has effectively produced periodic increases in heart rate or PTT without producing EEG arousals and shown an independent relationship to outcome variables. One study of "nonvisible" arousals 36 did show significant decreases in function on the following day, but 20% of the arousals actually produced traditional EEG arousals. Another study that used tones every 22 seconds for 30 days to produce consistent EEG, heart rate, and finger pulse volume responses did not find signs of sleepiness or performance decline. 81 Additional empirical studies are needed to explore the relationship between repetitive physiological arousal without EEG arousal during sleep and residual function to understand if this is a graded effect (less sleep restoration as sleep disturbance increases), a threshold effect (physiological activation above a certain level produces decreased restoration), or an interaction between physiological systems. Such studies are also important because they will inform about both the process of sleep restoration and perhaps the key physiological requirements. Finally, this work is required to support a broader definition of arousal. There is currently no compelling evidence to support the scoring evoked delta or K-complex activity as being similar to ASDA arousals. There is insufficient evidence to support the scoring of increases in physiological measures such as heart rate in the absence of EEG changes as compromising restoration during sleep.
Practical considerations and technical implications
A number of suggestions have been made to improve the ability to score arousals. Perhaps the major issue is training and experience. Because EEG arousals are short, they can be easily confused with artifact or overlooked during scoring. Scorers need directed training on gold-standard sleep recordings; this training should be repeated periodically. Other important issues include whether an occipital channel is included in the recording and which EEG channels are used to score arousals (the number of arousals scored would be expected to be larger if 2 occipital and 2 central channels are recorded and events can be selected from any of the 4 channels compared to a single central EEG channel). Arousal reliability might be further increased if EEG changes were required to be accompanied by a heart rate change.
Another issue that might improve reliability is calibration measurements. Although it is not possible for patients to produce an arousal from sleep response during calibrations, knowing whether the patient produces alpha is important. Production of eyes-closed alpha at a given amplitude could be linked to specific alpha criteria to be used for arousals, while inability to produce such an alpha response could be used to justify less stringent requirements. Such rules might be particularly helpful in patients with very low levels of alpha or with alpha-delta patterns. More specific alpha and EMG requirements would also improve computer scoring of arousals. EMG increases scored for arousals related to REM sleep are usually derived from the submental lead. Typically, the duration of increased EMG is for a minimum of one second. Standardized submental derivations for EMG and specifications for duration of EMG increase would improve arousal scoring, especially in REM where EMG increase is required.
Unresolved issues and future research
Understanding of the role of brief arousal in the sleep process has the potential to provide much information about the time course and function of sleep. Despite a fairly clear behavioral understanding of the impact of these brief events on the sleep process, little neurophysiological data exist to help understand the mechanism of arousal. Such work may provide more specific suggestions for new measures of arousal or more precise definitions for arousal events.
More precise definition of arousal events and improved computer scoring algorithms will improve automated scoring of arousals. However, to the extent that computer scored arousal events differ from visually scored events, it will again be important to repeat validity studies to ensure that such computer scored events are the same as visually scored events in their impact upon sleep restoration. In addition, it is likely that EEG arousals vary with some diseases and medications. Additional research will be required to fully define many arousal parameters.
AROUSAL TASK FORCE MEMBERS
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